Class IA phosphatidylinositol 3-kinase: from their biologic implication in human cancers to drug discovery
- 22 January 2008
- journal article
- review article
- Published by Informa UK Limited in Emerging Therapeutic Targets
- Vol. 12 (2), 223-238
- https://doi.org/10.1517/14728222.12.2.223
Abstract
Background: A substantial number of epidemiologic and experimental studies support an important role for Class I phosphatidylinositol 3-kinases (PI3Ks) in the biology of human cancer. Objective: This article reviews the authors' understanding of the role of Class IA PI3K in the biology of human cancers and present discovery efforts to identify and develop inhibitors of this class of lipid kinases. Methods: Books, journals, databases and websites have been searched to find the latest information on the subject. Results/conclusions: In spite of the progress made over the past few years, more studies are still needed to better understand the biology of this pathway, its interaction(s) with other signaling cascades, and the role of the individual paralogs and PI3Kα mutants in human cancer. From a drug discovery perspective, medicinal chemistry efforts have led to the discovery of new pan-PI3K and isoform selective inhibitors with improved specificity, potency and pharmaceutical properties. Phase I clinical studies have been initiated with some of these PI3K inhibitors and the efficacy and therapeutic index of this new generation of anticancer agents is eagerly awaited.Keywords
This publication has 107 references indexed in Scilit:
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Evidence for functional redundancy of class IA PI3K isoforms in insulin signallingBiochemical Journal, 2007
- The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformationProceedings of the National Academy of Sciences, 2006
- Phosphoinositide 3-Kinase C2β Regulates Cytoskeletal Organization and Cell Migration via Rac-dependent MechanismsMolecular Biology of the Cell, 2006
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaCancer Cell, 2006
- Cancer genes and the pathways they controlNature Medicine, 2004
- The Hallmarks of CancerCell, 2000
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994